Ceribell to Report Q4 and Full Year 2025 Financials

Medical device company Ceribell will announce its latest earnings on February 24, 2026.

Published on Feb. 10, 2026

Got story updates? Submit your updates here. ›

Ceribell, Inc., a medical device company focused on brain monitoring technology, announced it will report its fourth quarter and full year 2025 financial results on February 24, 2026. The company, which trades on the Nasdaq exchange under the ticker symbol CBLL, is headquartered in Sunnyvale, California.

Why it matters

As a publicly traded company, Ceribell's quarterly and annual financial reports are closely watched by investors to gauge the performance and growth trajectory of the business. The company's brain monitoring devices are used in hospitals and clinics, making its financial health an important indicator of the broader medical device industry.

The details

Ceribell develops and markets a suite of brain monitoring devices used to detect seizures and other neurological conditions. The company went public in 2023 and has continued to grow its revenue and product offerings over the past few years.

  • Ceribell will report its Q4 and full year 2025 financial results on February 24, 2026.

The players

Ceribell, Inc.

A medical device company focused on brain monitoring technology that trades on the Nasdaq exchange under the ticker symbol CBLL.

Got photos? Submit your photos here. ›

The takeaway

Ceribell's upcoming financial report will provide insight into the company's performance and growth in the medical device market, which has seen increased demand for advanced brain monitoring technologies in recent years.